160 related articles for article (PubMed ID: 38604404)
21. Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.
Hua J; Zhang W; Cao HF; Du CL; Ma JY; Zuo YH; Zhang J
BMJ Open; 2020 May; 10(5):e034804. PubMed ID: 32385061
[TBL] [Abstract][Full Text] [Related]
22. Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.
Price DB; Yang S; Ming SWY; Hardjojo A; Cabrera C; Papaioannou AI; Loukides S; Kritikos V; Bosnic-Anticevich SZ; Carter V; Dorinsky PM
Int J Chron Obstruct Pulmon Dis; 2018; 13():3937-3946. PubMed ID: 30587952
[TBL] [Abstract][Full Text] [Related]
23. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
Droszcz W; Droscez P
Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
[TBL] [Abstract][Full Text] [Related]
24. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
25. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
26. Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
Suriyakul A; Saiphoklang N; Barjaktarevic I; Cooper CB
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553057
[TBL] [Abstract][Full Text] [Related]
27. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
Leving MT; van Boven JFM; Bosnic-Anticevich SZ; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; García Pardo M; Gardev A; Gawlik R; van der Ham I; Hartgers-Gubbels ES; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price DB; Roman-Rodríguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani OS; Kocks JH
Int J Chron Obstruct Pulmon Dis; 2022; 17():2401-2415. PubMed ID: 36185173
[TBL] [Abstract][Full Text] [Related]
28. Exhalation immediately before inhalation optimizes dry powder inhaler use.
Kondo T; Hibino M; Tanigaki T; Ohe M; Kato S
J Asthma; 2015; 52(9):935-9. PubMed ID: 26513654
[TBL] [Abstract][Full Text] [Related]
29. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.
Seheult JN; Costello S; Tee KC; Bholah T; Al Bannai H; Sulaiman I; Costello RW
Springerplus; 2014; 3():496. PubMed ID: 25279290
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Associated Factors of Suboptimal Daily Peak Inspiratory Flow and Technique Misuse of Dry Powder Inhalers in Outpatients with Stable Chronic Airway Diseases.
Ding N; Zhang W; Wang Z; Bai C; He Q; Dong Y; Feng X; Zhang J; Gao S
Int J Chron Obstruct Pulmon Dis; 2021; 16():1913-1924. PubMed ID: 34188467
[TBL] [Abstract][Full Text] [Related]
31. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.
Murugaiya S; Murugesan B; S P
Cureus; 2024 Apr; 16(4):e58670. PubMed ID: 38774171
[TBL] [Abstract][Full Text] [Related]
33. Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.
Mahler DA; Halpin DMG
Chest; 2024 Feb; 165(2):323-332. PubMed ID: 37977266
[TBL] [Abstract][Full Text] [Related]
34. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.
Baloira A; Abad A; Fuster A; García Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL; González-Torralba F
Int J Chron Obstruct Pulmon Dis; 2021; 16():1021-1033. PubMed ID: 33907390
[TBL] [Abstract][Full Text] [Related]
35. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD.
Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A
Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863
[TBL] [Abstract][Full Text] [Related]
36. Monitoring Inhaler Inhalations Using an Acoustic Sensor Proximal to Inhaler Devices.
Taylor TE; Holmes MS; Sulaiman I; Costello RW; Reilly RB
J Aerosol Med Pulm Drug Deliv; 2016 Oct; 29(5):439-446. PubMed ID: 26859629
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
38. Lung deposition of inhaled once-daily long-acting muscarinic antagonists
Crater GD; Johnson K; Ward J; Backer J
Ther Adv Respir Dis; 2022; 16():17534666221077561. PubMed ID: 35234085
[TBL] [Abstract][Full Text] [Related]
39. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.
Hira D; Koide H; Nakamura S; Okada T; Ishizeki K; Yamaguchi M; Koshiyama S; Oguma T; Ito K; Funayama S; Komase Y; Morita SY; Nishiguchi K; Nakano Y; Terada T
PLoS One; 2018; 13(2):e0193082. PubMed ID: 29462195
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation.
Sharma G; Mahler DA; Mayorga VM; Deering KL; Harshaw O; Ganapathy V
Chronic Obstr Pulm Dis; 2017 Jul; 4(3):217-224. PubMed ID: 28848933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
